유전성 난청

Regeneron’s Otarmeni marks the first neurosensory gene therapy to reach the market, yet its rapid path through the FDA raises questions about long-term efficacy and the high cost … 4월 24, 2026

A single injection of AAV gene therapy delivered a working OTOF gene and improved hearing in ten patients within weeks, researchers report. The results are striking for one rare f… 4월 05, 2026

Eli Lilly has inked an exclusive research and licensing deal with Seamless Therapeutics worth up to $1.12 billion to develop programmable recombinase gene-editing therapies for in… 1월 28, 2026

A new study links rare CPD gene mutations to congenital hearing loss and shows that restoring arginine–nitric oxide signaling — with supplements or sildenafil — rescues auditory c… 11월 18, 2025